165
Participants
Start Date
March 28, 2022
Primary Completion Date
December 12, 2023
Study Completion Date
December 12, 2023
9vHPV Vaccine
9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular (IM) injection
mRNA-1273 Vaccine
mRNA-1273 50 mcg dose administered as a 0.25-mL IM injection
Certified Research Associates ( Site 0090), Cortland
Corning Center for Clinical Research ( Site 0091), Horseheads
Thomas Jefferson University - Family and Community Medicine ( Site 0006), Philadelphia
Emerson Clinical Research Institute ( Site 0021), Washington D.C.
CBH Health ( Site 0019), Gaithersburg
M3 Wake Research, Inc. ( Site 0014), Raleigh
Carolina Institute for Clinical Research, LLC ( Site 0042), Fayetteville
Mount Vernon Clinical Research ( Site 0053), Sandy Springs
Atlanta Center for Medical Research ( Site 0055), Atlanta
Accel Research Sites-DeLand Clinical Research Unit ( Site 0066), DeLand
Acevedo Clinical Research Associates ( Site 0001), Miami
Alpha Science Research ( Site 0067), Miami
Comprehensive Clinical Research ( Site 0038), West Palm Beach
Advanced Research For Health Improvement LLC ( Site 0075), Naples
Advanced Research for Health Improvement, LLC ( Site 0012), Immokalee
WR-ClinSearch ( Site 0049), Chattanooga
SKY Integrative Medical Center/SKYCRNG ( Site 0084), Ridgeland
Dayton Clinical Research ( Site 0028), Dayton
Midwest Children's Health Research Institute ( Site 0003), Lincoln
Preferred Research Partners Inc. ( Site 0092), Little Rock
Children's Clinic of Jonesboro, PA ( Site 0044), Jonesboro
West Houston Clinical Research Services ( Site 0078), Houston
Next Level Urgent Care, LLC ( Site 0099), Houston
University of Texas Medical Branch ( Site 0026), League City
Milton Haber, M.D. ( Site 0069), Laredo
South Texas Clinical Research ( Site 0024), Corpus Christi
DermResearch, Inc. ( Site 0056), Austin
South Texas Pediatric Research Group ( Site 0094), Del Rio
Clinical Research Prime ( Site 0088), Idaho Falls
Velocity Clinical Research, Salt Lake City ( Site 0025), West Jordan
University of Utah ( Site 0076), Salt Lake City
Cognitive Clinical Trials, LLC ( Site 0054), Phoenix
Eclipse Clinical Research ( Site 0095), Tucson
Coast Clinical Research, LLC ( Site 0027), Bellflower
Ark Clinical Research ( Site 0098), Long Beach
Valley Clinical Trials Inc. ( Site 0004), Northridge
Medical Center for Clinical Research ( Site 0051), San Diego
Ark Clinical Research ( Site 0108), Tustin
Merck Sharp & Dohme LLC
INDUSTRY